Atjaunināt sīkdatņu piekrišanu

E-grāmata: Constitutive Activity in Receptors and Other Proteins, Part B

Volume editor (The Salk Institute, La Jolla, CA, USA)
  • Formāts: PDF+DRM
  • Sērija : Methods in Enzymology
  • Izdošanas datums: 24-Nov-2010
  • Izdevniecība: Academic Press Inc
  • Valoda: eng
  • ISBN-13: 9780123812971
Citas grāmatas par šo tēmu:
  • Formāts - PDF+DRM
  • Cena: 153,85 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
  • Formāts: PDF+DRM
  • Sērija : Methods in Enzymology
  • Izdošanas datums: 24-Nov-2010
  • Izdevniecība: Academic Press Inc
  • Valoda: eng
  • ISBN-13: 9780123812971
Citas grāmatas par šo tēmu:

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

This volume of Methods in Enzymology covers the current methodology for the detection and assessment of constitutively active proteins. The chapters written by expert authors who are leaders in the field, provide hints and tricks not available in primary research publications.It is extensively referenced, with useful figures and tables throughout the volume.

A. Expert authors who are leaders in the field

B. Extensively referenced and useful figures and tables

C. Provides hints and tricks to facilitate reproduction of methods



This volume of Methods in Enzymology covers the current methodology for the detection and assessment of constitutively active proteins. The chapters written by expert authors who are leaders in the field, provide hints and tricks not available in primary research publications.It is extensively referenced, with useful figures and tables throughout the volume.

A. Expert authors who are leaders in the field

B. Extensively referenced and useful figures and tables

C. Provides hints and tricks to facilitate reproduction of methods

Papildus informācija

This volume of Methods in Enzymology covers the current methodology for the detection and assessment of constitutively active proteins.
Contributors xv
Preface xxiil
Volumes in Series xxv
Section I Inverse Agonism and Inverse Agonists
1(274)
1 Identification and Characterization of Steroidogenic Factor-1 Inverse Agonists
3(22)
Mabrouka Doghman
Franck Madoux
Peter Hodder
Enzo Lalli
1 Introduction
4(2)
2 Characterization of Inverse Agonists of SF-1 by uHTS
6(11)
3 Effect of SF-1 Inverse Agonists on Adrenocortical Tumor Cell Proliferation and Sterold Production
17(3)
4 Conclusion
20(2)
Acknowledgments
22(1)
References
22(3)
2 Assessment of Inverse Agonism for the Angiotensin II Type 1 Receptor
25(12)
Hiroshi Akazawa
Noritaka Yasuda
Shin-Ichiro Miura
Issei Komuro
1 Introduction
26(1)
2 Protocol for Cell Culture and Transfection
26(1)
3 Radioligand Assay for AT1 Receptor
27(1)
4 Protocol for Cell Stretching
28(2)
5 Assessment of AT1 Receptor Activation
30(3)
6 Conclusion
33(1)
Acknowledgments
34(1)
References
34(3)
3 Measurement of Inverse Agonism in β-Adrenoceptors
37(24)
Carlos A. Taira
Federico Monczor
Christian Hocht
1 Introduction: Basal Spontaneous Receptor Activity. The Rise of the Concept of Inverse Agonism
38(4)
2 β-Adrenoceptors: Main Features
42(3)
3 Methodological Aspects of the Assessment of Inverse Agonist Properties at βAR
45(6)
4 Clinical Potential Uses of βAR Inverse Agonists
51(2)
References
53(8)
4 Techniques for Studying Inverse Agonist Activity of Antidepressants at Recombinant Nonedited 5-HT2C-INI Receptor and Native Neuronal 5-HT2C Receptors
61(20)
Mathieu Seimandi
Joel Bockaert
Philippe Marin
1 Introduction
62(3)
2 Constitutive Activity Toward the Gαq-PLC Effector Pathway of 5-HT2C-INI Receptors Transiently Expressed in HEK-293 Cells
65(6)
3 Plasma Membrane Insertion of 5-HT2C-INI Receptors
71(2)
4 Enhanced Responsiveness of Constitutively Active 5-HT2C Receptors Upon Prolonged Treatment with Inverse Agonists
73(4)
Acknowledgments
77(1)
References
77(4)
5 Differential Inverse Agonism at the Human Muscarinic M3 Receptor
81(22)
Paola Casarosa
Tobias Kiechle
Remko A. Bakker
1 Introduction to Muscarinic Receptors
82(2)
2 Role of M3R in Regulating Smooth Muscle Function and Clinical Use of Anticholinergics
84(1)
3 In Vitro Assays to Monitor hM3R Activation and Constitutive Activity
85(10)
4 Constitutive Activity and Receptor Upregulation Studies
95(3)
5 Physiological Relevance of hM3R Constitutive Activity
98(2)
References
100(3)
6 Ghrelin Receptor: High Constitutive Activity and Methods for Developing Inverse Agonists
103(20)
Sylvia Els
Annette G. Beck-Sickinger
Constance Chollet
1 Introduction
104(1)
2 Constitutive Activity and Development of Ghrelin Receptor Inverse Agonists
105(2)
3 Synthesis of Ghrelin Receptor Inverse Agonists: Solid-Phase Peptide Synthesis (SPPS)
107(6)
4 Functional Assays for Ghrelin Receptor Inverse Agonists
113(6)
References
119(4)
7 Constitutive Activity and Inverse Agonism at the α1a and α1b Adrenergic Receptor Subtypes
123(16)
Susanna Cotecchia
1 Introduction
124(3)
2 Combination of Computational Modeling and Site-Directed Mutagenesis of the Receptor to Identify Constitutively Activating Mutations
127(3)
3 Measuring Constitutive Activity of Receptor-Mediated Gq Activation
130(2)
4 Inverse Agonism at the α1-ARs
132(3)
5 Conclusions
135(1)
Acknowledgments
136(1)
References
136(3)
8 Measurement of Inverse Agonism of the Cannabinoid Receptors
139(8)
Tung M. Fong
1 Introduction
139(1)
2 Gi-cAMP Assay
140(2)
3 GTPγS Binding Assay
142(1)
4 Electrophysiological Assays
143(1)
5 Summary
143(1)
References
144(3)
9 Constitutively Active Thyrotropin and Thyrotropin-Releasing Hormone Receptors and Their Inverse Agonists
147(14)
Susanne Neumann
Bruce M. Raaka
Marvin C. Gershengorn
1 Introduction
148(1)
2 TRH-R2 and Its Inverse Agonist Midazolam
149(4)
3 TSHR and Its Inverse Agonist NCGC00161856
153(6)
Acknowledgments
159(1)
References
159(2)
10 Inverse Agonists and Antagonists of Retinoid Receptors
161(36)
William Bourguet
Angel R. de Lera
Hinrich Gronemeyer
1 Introduction
162(2)
2 Functional Classification of Retinoid Receptor Ligands
164(1)
3 Structural Basis of Retinoid Receptor Action
165(4)
4 Synthetic Routes and Toolbox for Rational Retinoid Design
169(8)
5 Protocols for the Study of Ligand Function
177(13)
6 Chemical Syntheses
190(1)
Acknowledgments
191(1)
References
192(5)
11 γ-Aminobutyric Acid Type A (GABAA) Receptor Subtype Inverse Agonists as Therapeutic Agents in Cognition
197(16)
Guerrini Gabriella
Ciciani Giovanna
1 Introduction
198(5)
2 Inverse Agonism: Definition
203(1)
3 Negative Allosteric Regulators of GABAA-R in Cognitive Impairment
204(2)
4 Methods for Evaluating the Affinity and Efficacy at GABAA Receptor Subtypes
206(2)
5 Conclusion
208(1)
References
208(5)
12 Assays for Inverse Agonists in the Visual System
213(12)
Masahiro Kono
1 Introduction
214(4)
2 Opsin Preparation
218(1)
3 Transducin Preparation
219(1)
4 Transducin Activation Assay
219(2)
Acknowledgments
221(1)
References
221(4)
13 Receptor-Driven Identification of Novel Human A3 Adenosine Receptor Antagonists as Potential Therapeutic Agents
225(20)
Silvia Paoletta
Stephanie Federico
Giampiero Spalluto
Stefano Moro
1 Introduction
226(1)
2 Newer Potential Therapeutic Role of A3 Adenosine Receptors
226(2)
3 A3 Adenosine Receptor Antagonists
228(3)
4 Receptor-Based Antagonist Design
231(12)
Acknowledgments
243(1)
References
243(2)
14 Inverse Agonist Activity of Steroidogenic Factor SF-1
245(16)
Fabrice Piu
Andria L. Del Tredici
1 Introduction
246(1)
2 SF-1 Inverse Agonism in the R-SAT® Assay of Cellular Proliferation
247(4)
3 SF-1 Inverse Agonism in Luciferase Transcriptional Assay
251(3)
4 SF-1 Inverse Agonism in Adrenocortical Cultures
254(3)
Acknowledgments
257(1)
References
257(4)
15 Methods to Measure G-Protein-Coupled Receptor Activity for the Identification of Inverse Agonists
261(14)
Gabriel Barreda-Gomez
M. Teresa Giralt
Rafael Rodriguez-Puertas
1 Introduction
262(4)
2 [ 35S]GTPγS Binding Assay in Membrane Homogenates
266(4)
3 [ 35S]GTPγS Autoradiography in Brain Sections
270(2)
Acknowledgments
272(1)
References
273(2)
Section II Novel Strategies and Techniques for Constitutive Activity and Inverse Agonism
275(336)
16 Use of Pharmacoperones to Reveal GPCR Structural Changes Associated with Constitutive Activation and Trafficking
277(16)
Jo Ann Janovick
P. Michael Conn
1 Introduction
278(1)
2 Methods for Measuring Receptors and Receptor Activity
279(4)
3 Assessment of Results
283(7)
4 Conclusions
290(1)
Acknowledgments
290(1)
References
290(3)
17 Application of Large-Scale Transient Transfection to Cell-Based Functional Assays for Ion Channels and GPCRs
293(18)
Jun Chen
Sujatha Gopalakrishnan
Marc R. Lake
Bruce R. Bianchi
John Locklear
Regina M. Reilly
1 Introduction
294(1)
2 Large-Scale Transient Transfection
295(1)
3 Cryopreservation of Cells
296(1)
4 Application to Ion Channel Assays
297(8)
5 Application to GPCR Assays
305(3)
6 Conclusion
308(1)
Acknowledgment
309(1)
References
309(2)
18 Quantification of RNA Editing of the Serotonin 2C Receptor (5-HT2CR) Ex Vivo
311(18)
Maria Fe Lanfranco
Noelle C. Anastasio
Patricia K. Seitz
Kathryn A. Cunningham
1 RNA Editing of the 5-HT2CR
312(2)
2 Functional Properties of 5-HT2CR Edited Isoforms
314(1)
3 Current Methods for Quantification of 5-HT2CR Editing Events Ex Vivo
315(3)
4 Quantification of 5-HT2CR Editing Events Ex Vivo with qRT-PCR
318(7)
Acknowledgments
325(1)
References
325(4)
19 Strategies for Isolating Constitutively Active and Dominant-Negative Pheromone Receptor Mutants in Yeast
329(20)
Mercedes Dosil
James B. Konopka
1 Introduction
330(2)
2 Selecting a Yeast Strain and Expression Vector
332(3)
3 Transforming Plasmids into Yeast
335(2)
4 "Gap-Repair" Approach for Targeting Mutagenesis to Genes on Plasmids
337(1)
5 Isolation of Constitutively Active Mutants
338(4)
6 Isolation of Dominant-Negative Mutants
342(2)
7 Further Methods for Analysis of Mutant Receptors
344(3)
Acknowledgments
347(1)
References
347(2)
20 Development of a GPR23 Cell-Based β-Lactamase Reporter Assay
349(20)
Paul H. Lee
Bonnie J. Hanson
1 Introduction
350(2)
2 GPCR Cell-Based Assays
352(5)
3 Development of a Cell-Based β-Lactamase Reporter Assay for Constitutively Active GPR23
357(5)
4 Identification of GPR23 Inverse Agonists Using a β-Lactamase Reporter Screen
362(3)
5 Concluding Remarks
365(1)
Acknowledgments
366(1)
References
366(3)
21 Computational Modeling of Constitutively Active Mutants of GPCRs: C5a Receptor
369(24)
Gregory V. Nikiforovich
Thomas J. Baranski
1 Introduction
370(1)
2 Modeling CAMs Based on Experimental Data for the Ground and Activated States of GPCRs
371(6)
3 Rotational Sampling of the TM Regions of GPCRs
377(5)
4 Modeling Structural Mechanisms of Constitutive Activity in C5aRs
382(5)
5 Conclusions and Perspectives
387(1)
Acknowledgments
387(1)
References
387(6)
22 TSH Receptor Monoclonal Antibodies with Agonist, Antagonist, and Inverse Agonist Activities
393(28)
Jane Sanders
Ricardo Nunez Miguel
Jadwiga Furmaniak
Bernard Rees Smith
1 Introduction
394(3)
2 Production of Monoclonal Antibodies to the TSHR with the Characteristics of Patient Serum Autoantibodies
397(2)
3 Characterization of 5C9 a Human Autoantibody with TSH Antagonist and TSHR Inverse Agonist Activity
399(6)
4 Effects of TSHR Mutations on the Activity of MAb 5C9
405(7)
5 Structure of MAb 5C9 Fab
412(3)
6 Conclusions
415(1)
Acknowledgment
416(1)
References
417(4)
23 Current Standards, Variations, and Pitfalls for the Determination of Constitutive TSHR Activity In Vitro
421(16)
Sandra Mueller
Holger Jaeschke
Ralf Paschke
1 Introduction
422(3)
2 Detection of Constitutive TSHR Activity
425(4)
3 Methods and Required Materials for LRA
429(3)
4 Conclusion
432(1)
Acknowledgment
433(1)
References
433(4)
24 Toward the Rational Design of Constitutively Active KCa3.1 Mutant Channels
437(22)
Line Garneau
Helene Klein
Lucie Parent
Remy Sauve
1 Introduction
438(3)
2 Production of Constitutively Active KCa3.1 Mutant Channels
441(13)
3 Concluding Remarks
454(1)
References
455(4)
25 Fusion Proteins as Model Systems for the Analysis of Constitutive GPCR Activity
459(22)
Erich H. Schnelder
Roland Seifert
1 Introduction
460(2)
2 Expression of Fusion Proteins: hH4R-Gα12 and hH4R-GAIP as Paradigms
462(4)
3 Investigation of GPCR Constitutive Activity with Fusion Proteins: H4R as Paradigm
466(10)
4 Application of the Fusion Protein Approach to other GPCRs
476(2)
Acknowledgments
478(1)
References
479(2)
26 Screening for Novel Constitutively Active CXCR2 Mutants and Their Cellular Effects
481(18)
Giljun Park
Tom Masi
Chang K. Choi
Heejung Kim
Jeffrey M. Becker
Tim E. Sparer
1 Introduction
482(1)
2 Establishment of a Yeast System to Identify CXCR2 CAMs
483(7)
3 Establishment of a Mammalian System to Characterize CXCR2 CAMs
490(5)
References
495(4)
27 A Method for Parallel Solid-Phase Synthesis of Iodinated Analogs of the Cannabinoid Receptor Type I (CB1) Inverse Agonist Rimonabant
499(28)
Alan C. Spivey
Chih-Chung Tseng
1 Introduction
500(4)
2 Concepts for Molecular Imaging
504(1)
3 Conventional Methods for Preparation of Radiolabeled Pharmaceuticals for Imaging the CB1 Receptor
504(5)
4 Parallel Solid-Phase Synthesis of lodinated Analogs of the CB1 Receptor Inverse Agonist Rimonabant
509(5)
5 Materials and Methods
514(9)
References
523(4)
28 Coexpression Systems as Models for the Analysis of Constitutive GPCR Activity
527(32)
Erich H. Schnelder
Roland Seifert
1 Introduction
528(1)
2 Coexpression of GPCRs and Signaling Proteins: hH4R as Paradigm
529(6)
3 Investigation of GPCR Constitutive Activity with Coexpression Systems
535(19)
4 Application to Other Receptors
554(2)
Acknowledgments
556(1)
References
556(3)
29 Modeling and Simulation of Inverse Agonism Dynamics
559(24)
L.J. Bridge
1 Introduction
560(3)
2 Single-Ligand Analysis
563(6)
3 Two Competing Ligands
569(9)
4 Discussion
578(3)
Acknowledgments
581(1)
References
582(1)
30 Design and Use of Constitutively Active STAT5 Constructs
583(14)
Michael A. Farrar
1 Introduction
583(2)
2 Design of Constitutively Active STAT5 Constructs
585(4)
3 Use of Constitutively Active STAT5 Constructs
589(4)
4 Concerns with the Use of Constitutively Active STAT5 Constructs
593(2)
Acknowledgments
595(1)
References
595(2)
31 In Vitro and In Vivo Assays of Protein Kinase CK2 Activity
597(14)
Renaud Prudent
Celine F. Sautel
Virginie Moucadel
Beatrice Laudet
Odile Filhol
Claude Cochet
1 Introduction
598(1)
2 Monitoring of CK2 Catalytic Activity in Living Cells
598(3)
3 Assays of CK2 Subunit Interaction
601(2)
4 Visualization of CK2α-CK2β Interaction in Living Cells
603(6)
Acknowledgments
609(1)
References
609(2)
Author Index 611(28)
Subject Index 639